Dermata Therapeutics, Inc.
DRMA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,162 | $7,438 | $6,241 | $10,799 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $8 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $13 | -$8 | $105 | $56 |
| Total Curr. Assets | $3,534 | $7,979 | $6,944 | $11,624 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,534 | $7,979 | $6,944 | $11,624 |
| Liabilities | – | – | – | – |
| Payables | $808 | $866 | $497 | $515 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $716 | -$0 | $0 |
| Total Curr. Liab. | $1,973 | $1,624 | $923 | $1,517 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | -$0 | -$0 |
| Total NC Liab. | $0 | $0 | -$0 | -$0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,973 | $1,624 | $923 | $1,517 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $1 |
| Retained Earnings | -$65,675 | -$53,388 | -$45,593 | -$35,982 |
| AOCI | -$0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $1,561 | $6,355 | $6,022 | $10,107 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,534 | $7,979 | $6,944 | $11,624 |
| Net Debt | -$3,162 | -$7,438 | -$6,241 | -$10,799 |